Alberta Investment Management Corp (AIMCo)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-12,600
| Closed | -$5.01M | – | 594 |
|
|
2025
Q4 | $5.01M | Buy |
12,600
+900
| +8% | +$398K | 0.03% | 347 |
|
|
2025
Q3 | $5.34M | Buy |
+11,700
| New | +$4.76M | 0.04% | 251 |
|
|
2025
Q2 | – | Sell |
-17,700
| Closed | -$4.78M | – | 578 |
|
|
2025
Q1 | $4.78M | Sell |
17,700
-300
| -2% | -$77.1K | 0.03% | 292 |
|
|
2024
Q4 | $4.24M | Buy |
18,000
+11,100
| +161% | +$2.92M | 0.03% | 311 |
|
|
2024
Q3 | $1.9M | Buy |
+6,900
| New | +$1.8M | 0.02% | 442 |
|
|
2024
Q2 | – | Sell |
-2,900
| Closed | -$433K | – | 713 |
|
|
2024
Q1 | $433K | Sell |
2,900
-4,275
| -60% | -$713K | ﹤0.01% | 840 |
|
|
2023
Q4 | $1.37M | Buy |
7,175
+4,275
| +147% | +$728K | 0.01% | 544 |
|
|
2023
Q3 | $514K | Hold |
2,900
| – | – | 0.01% | 807 |
|
|
2023
Q2 | $551K | Hold |
2,900
| – | – | 0.01% | 918 |
|
|
2023
Q1 | $581K | Buy |
+2,900
| New | +$610K | 0.01% | 931 |
|
|
2021
Q3 | – | Sell |
-84,800
| Closed | -$14.4M | – | 961 |
|
|
2021
Q2 | $14.4M | Sell |
84,800
-4,000
| -5% | -$586K | 0.12% | 188 |
|
|
2021
Q1 | $12.5M | Sell |
88,800
-5,500
| -6% | -$828K | 0.11% | 197 |
|
|
2020
Q4 | $12.3M | Buy |
94,300
+13,300
| +16% | +$1.78M | 0.11% | 217 |
|
|
2020
Q3 | $11.8M | Buy |
81,000
+10,500
| +15% | +$1.49M | 0.13% | 189 |
|
|
2020
Q2 | $10.4M | Buy |
70,500
+18,500
| +36% | +$2.49M | 0.12% | 206 |
|
|
2020
Q1 | $5.66M | Hold |
52,000
| – | – | 0.1% | 241 |
|
|
2019
Q4 | $5.99M | Sell |
52,000
-11,400
| -18% | -$1.14M | 0.05% | 311 |
|
|
2019
Q3 | $5.1M | Sell |
63,400
-24,500
| -28% | -$1.94M | 0.05% | 332 |
|
|
2019
Q2 | $6.38M | Buy |
87,900
+27,900
| +47% | +$2.14M | 0.06% | 294 |
|
|
2019
Q1 | $5.61M | Buy |
+60,000
| New | +$5.02M | 0.05% | 296 |
|
|
2018
Q2 | – | Sell |
-56,200
| Closed | -$6.69M | – | 818 |
|
|
2018
Q1 | $6.69M | Buy |
56,200
+44,500
| +380% | +$5.74M | 0.06% | 297 |
|
|
2017
Q4 | $1.49M | Sell |
11,700
-7,500
| -39% | -$942K | 0.01% | 488 |
|
|
2017
Q3 | $2.26M | Buy |
+19,200
| New | +$1.64M | 0.02% | 443 |
|
|
2017
Q1 | – | Sell |
-14,900
| Closed | -$558K | – | 798 |
|
|
2016
Q4 | $558K | Buy |
+14,900
| New | +$624K | 0.01% | 593 |
|
|
2015
Q3 | – | Sell |
-7,200
| Closed | -$863K | – | 498 |
|
|
2015
Q2 | $863K | Buy |
+7,200
| New | +$860K | 0.01% | 469 |
|
Other funds holding ALNY
Alberta Investment Management Corp (AIMCo)'s ALNY Position: Q1 2026 in Review
Alberta Investment Management Corp (AIMCo) sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2026, closing a stake of 12,600 shares — an estimated $5.01M sold.
Alberta Investment Management Corp (AIMCo) first reported a position in ALNY in Q2 2015 and held it in 25 quarters. The position peaked at $14.4M in Q2 2021. 793 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.
- Alberta Investment Management Corp (AIMCo) reported no remaining Alnylam Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Alberta Investment Management Corp (AIMCo) sold 12,600 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $5.01M.
- Alberta Investment Management Corp (AIMCo) first reported a position in Alnylam Pharmaceuticals in Q2 2015 and held it in 25 quarters.
- Alberta Investment Management Corp (AIMCo)'s Alnylam Pharmaceuticals position peaked at $14.4M in Q2 2021.
- 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.
Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.